Choline Deficiency

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Protara Therapeutics
1 program
1
Choline Chloride for InjectionPhase 2/31 trial
Active Trials
NCT06910943Recruiting129Est. Jun 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
Protara TherapeuticsCholine Chloride for Injection

Clinical Trials (1)

Total enrollment: 129 patients across 1 trials

NCT06910943Protara TherapeuticsCholine Chloride for Injection

Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support

Start: Dec 2025Est. completion: Jun 2028129 patients
Phase 2/3Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 129 patients
1 companies competing in this space